Cargando…

Epidemiological features of hypertension among ischemic survivors in Northeast China: insights from a population-based study, 2017–2019

BACKGROUND: Hypertension remains the major modifiable risk factor of stroke recurrence. The study aimed to determine the up-to-date epidemiological features of hypertension among the survivors of ischemic stroke. METHODS: Our cross-sectional study included 18,796 adults aged ≥40 years and residing i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Li, Tian, Yuanmeng, Ren, Guocheng, Zhang, Limin, Shi, Lei, Dai, Dong, Xing, Liying, Liu, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427863/
https://www.ncbi.nlm.nih.gov/pubmed/34503467
http://dx.doi.org/10.1186/s12889-021-11692-x
_version_ 1783750260974157824
author Jing, Li
Tian, Yuanmeng
Ren, Guocheng
Zhang, Limin
Shi, Lei
Dai, Dong
Xing, Liying
Liu, Shuang
author_facet Jing, Li
Tian, Yuanmeng
Ren, Guocheng
Zhang, Limin
Shi, Lei
Dai, Dong
Xing, Liying
Liu, Shuang
author_sort Jing, Li
collection PubMed
description BACKGROUND: Hypertension remains the major modifiable risk factor of stroke recurrence. The study aimed to determine the up-to-date epidemiological features of hypertension among the survivors of ischemic stroke. METHODS: Our cross-sectional study included 18,796 adults aged ≥40 years and residing in northeast China. Ischemic stroke was diagnosed according to the World Health Organization’s criteria, which requires the clinical record, computed tomography (CT) and/or magnetic resonance imaging (MRI) during the hospital stay. Hypertension was defined according to the Chinese hypertension guidelines (mean SBP ≥140 mmHg and/or mean DBP ≥90 mmHg, and/or self-reported use of anti-hypertensive medication in the past 2 weeks). RESULTS: Of the 986 survivors of ischemic stroke, 819 (83.1%) were identified with hypertension (535 were pre-stroke hypertension and 284 were post-stroke hypertension). Among hypertensive patients, the awareness and treatment rates were 76.8 and 66.7% respectively. Only 11.0% achieved an appropriate blood pressure (< 140 mmHg and < 90 mmHg) among those who took hypertensive medications. 16.8% of treated hypertensive patients received combination therapy, and calcium channel blockers were the most frequently used anti-hypertensive medication as monotherapy. The mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) of the stroke population was 155.3 ± 22.9 mmHg and 89.2 ± 12.3 mmHg. Both SBP and DBP were higher in rural patients than in urban patients (158.5 ± 23.8 mmHg vs. 146.4 ± 17.5 mmHg and 90.3 ± 12.9 mmHg vs. 85.9 ± 10.1 mmHg, respectively; p < 0.001). The rates of stage 2 and above hypertension in the ischemic stroke population were 32.5 and 18.7%, and was significantly higher in rural areas than in urban areas. CONCLUSIONS: The prevalence of poorly-controlled hypertension and the high rates of blood pressures at stages 2 and above in patients with prior ischemic stroke demonstrated an alarming situation in northeast China.
format Online
Article
Text
id pubmed-8427863
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84278632021-09-10 Epidemiological features of hypertension among ischemic survivors in Northeast China: insights from a population-based study, 2017–2019 Jing, Li Tian, Yuanmeng Ren, Guocheng Zhang, Limin Shi, Lei Dai, Dong Xing, Liying Liu, Shuang BMC Public Health Research BACKGROUND: Hypertension remains the major modifiable risk factor of stroke recurrence. The study aimed to determine the up-to-date epidemiological features of hypertension among the survivors of ischemic stroke. METHODS: Our cross-sectional study included 18,796 adults aged ≥40 years and residing in northeast China. Ischemic stroke was diagnosed according to the World Health Organization’s criteria, which requires the clinical record, computed tomography (CT) and/or magnetic resonance imaging (MRI) during the hospital stay. Hypertension was defined according to the Chinese hypertension guidelines (mean SBP ≥140 mmHg and/or mean DBP ≥90 mmHg, and/or self-reported use of anti-hypertensive medication in the past 2 weeks). RESULTS: Of the 986 survivors of ischemic stroke, 819 (83.1%) were identified with hypertension (535 were pre-stroke hypertension and 284 were post-stroke hypertension). Among hypertensive patients, the awareness and treatment rates were 76.8 and 66.7% respectively. Only 11.0% achieved an appropriate blood pressure (< 140 mmHg and < 90 mmHg) among those who took hypertensive medications. 16.8% of treated hypertensive patients received combination therapy, and calcium channel blockers were the most frequently used anti-hypertensive medication as monotherapy. The mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) of the stroke population was 155.3 ± 22.9 mmHg and 89.2 ± 12.3 mmHg. Both SBP and DBP were higher in rural patients than in urban patients (158.5 ± 23.8 mmHg vs. 146.4 ± 17.5 mmHg and 90.3 ± 12.9 mmHg vs. 85.9 ± 10.1 mmHg, respectively; p < 0.001). The rates of stage 2 and above hypertension in the ischemic stroke population were 32.5 and 18.7%, and was significantly higher in rural areas than in urban areas. CONCLUSIONS: The prevalence of poorly-controlled hypertension and the high rates of blood pressures at stages 2 and above in patients with prior ischemic stroke demonstrated an alarming situation in northeast China. BioMed Central 2021-09-09 /pmc/articles/PMC8427863/ /pubmed/34503467 http://dx.doi.org/10.1186/s12889-021-11692-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jing, Li
Tian, Yuanmeng
Ren, Guocheng
Zhang, Limin
Shi, Lei
Dai, Dong
Xing, Liying
Liu, Shuang
Epidemiological features of hypertension among ischemic survivors in Northeast China: insights from a population-based study, 2017–2019
title Epidemiological features of hypertension among ischemic survivors in Northeast China: insights from a population-based study, 2017–2019
title_full Epidemiological features of hypertension among ischemic survivors in Northeast China: insights from a population-based study, 2017–2019
title_fullStr Epidemiological features of hypertension among ischemic survivors in Northeast China: insights from a population-based study, 2017–2019
title_full_unstemmed Epidemiological features of hypertension among ischemic survivors in Northeast China: insights from a population-based study, 2017–2019
title_short Epidemiological features of hypertension among ischemic survivors in Northeast China: insights from a population-based study, 2017–2019
title_sort epidemiological features of hypertension among ischemic survivors in northeast china: insights from a population-based study, 2017–2019
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427863/
https://www.ncbi.nlm.nih.gov/pubmed/34503467
http://dx.doi.org/10.1186/s12889-021-11692-x
work_keys_str_mv AT jingli epidemiologicalfeaturesofhypertensionamongischemicsurvivorsinnortheastchinainsightsfromapopulationbasedstudy20172019
AT tianyuanmeng epidemiologicalfeaturesofhypertensionamongischemicsurvivorsinnortheastchinainsightsfromapopulationbasedstudy20172019
AT renguocheng epidemiologicalfeaturesofhypertensionamongischemicsurvivorsinnortheastchinainsightsfromapopulationbasedstudy20172019
AT zhanglimin epidemiologicalfeaturesofhypertensionamongischemicsurvivorsinnortheastchinainsightsfromapopulationbasedstudy20172019
AT shilei epidemiologicalfeaturesofhypertensionamongischemicsurvivorsinnortheastchinainsightsfromapopulationbasedstudy20172019
AT daidong epidemiologicalfeaturesofhypertensionamongischemicsurvivorsinnortheastchinainsightsfromapopulationbasedstudy20172019
AT xingliying epidemiologicalfeaturesofhypertensionamongischemicsurvivorsinnortheastchinainsightsfromapopulationbasedstudy20172019
AT liushuang epidemiologicalfeaturesofhypertensionamongischemicsurvivorsinnortheastchinainsightsfromapopulationbasedstudy20172019